Skip to main navigation Skip to search Skip to main content

Amlodipine Besylate-Excipients Interaction in Solid Dosage Form

  • A. Abdoh
  • , M. M. Al-Omari
  • , A. A. Badwan
  • , A. M.Y. Jaber*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Abstract

This article studies the compatibility of amlodipine besylate in its solid formulations with various drug excipients. The various factors affecting amlodipine besylate stability were studied using high-performance liquid chromatography (HPLC). It has been found that binary 1:1 mixtures of amlodipine besylate and an excipient are stable at 65°C and 40°C/75% RH. Further investigations were conducted to study the stability of amlodipine besylate in multicomponent mixtures, including mixtures with actual formulations. The study reveals that mixtures of lactose, magnesium stearate, and water induce some instability on amlodipine besylate. The major degradation product confirmed by HPLC-mass spectrometry is amlodipine besylate glycosyl. This is in conformity with the well-known Maillard reaction between primary amines and lactose. Thus, lactose-free amlodipine formulations are recommended from the safety, quality, efficacy, and process cost points of view.

Original languageEnglish
Pages (from-to)15-24
Number of pages10
JournalPharmaceutical Development and Technology
Volume9
Issue number1
DOIs
StatePublished - 2004

Bibliographical note

Funding Information:
The Jordanian Pharmaceutical Manufacturing Co. and the King Fahd University of Petroleum & Minerals are thanked for the support of this research project. Also, the authors want to thank Dr. N. Najeeb and Mr. Izz Al-Deen Ghanem at the International Pharmaceutical Research Center for their participation in the HPLC-MS spectroscopy testing.

Keywords

  • Amlodipine besylate
  • Compatibility
  • Excipients
  • HPLC
  • Maillard reaction

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Amlodipine Besylate-Excipients Interaction in Solid Dosage Form'. Together they form a unique fingerprint.

Cite this